BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang B, Chen S, Zheng Q, Li Y, Zhang X, Xuan J, Liu Y, Shi G. Early diagnosis and treatment for Sjögren's syndrome: current challenges, redefined disease stages and future prospects. J Autoimmun 2021;117:102590. [PMID: 33310686 DOI: 10.1016/j.jaut.2020.102590] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Izzetti R, Fulvio G, Nisi M, Gennai S, Graziani F. Reliability of OMERACT Scoring System in Ultra-High Frequency Ultrasonography of Minor Salivary Glands: Inter-Rater Agreement Study. J Imaging 2022;8:111. [DOI: 10.3390/jimaging8040111] [Reference Citation Analysis]
2 Chen L, Lu D, Yu K, He S, Liu L, Zhang X, Feng B, Wang X. Bioinformatics Analysis for Identification of Key Genes in Salivary Gland and the Potential of a Combination of Biomarkers for the Diagnosis of SS. J Inflamm Res 2021;14:4143-53. [PMID: 34475773 DOI: 10.2147/JIR.S322318] [Reference Citation Analysis]
3 Gerossier E, Nayar S, Froidevaux S, Smith CG, Runser C, Iannizzotto V, Vezzali E, Pierlot G, Mentzel U, Murphy MJ, Martinic MM, Barone F. Cenerimod, a selective S1P1 receptor modulator, improves organ-specific disease outcomes in animal models of Sjögren's syndrome. Arthritis Res Ther 2021;23:289. [PMID: 34839819 DOI: 10.1186/s13075-021-02673-x] [Reference Citation Analysis]
4 Ayesha B, Fernandez-Ruiz R, Shrock D, Snyder BM, Lieberman SM, Tuetken R, Field E, Singh N. Clinical and laboratory features of patients with focal lymphocytic sialadenitis on minor salivary gland biopsy for sicca symptoms: A single-center experience. Medicine (Baltimore) 2021;100:e25325. [PMID: 33787627 DOI: 10.1097/MD.0000000000025325] [Reference Citation Analysis]
5 Wang B, Chen S, Xuan J, Li Y, Zheng Q, Zhang X, Liu Y, Shi G. Correspondence on 'Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trial'. Ann Rheum Dis 2021:annrheumdis-2020-219666. [PMID: 33504477 DOI: 10.1136/annrheumdis-2020-219666] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Chen HH, Chen HM, Lin CH, Tang KT, Chen DY, Wei JC, Chao WC. Association of the Risk of Primary Sjögren's Syndrome With Fibrocystic Breast Disease: A Nationwide, Population-Based Study. Front Med (Lausanne) 2021;8:704593. [PMID: 34277672 DOI: 10.3389/fmed.2021.704593] [Reference Citation Analysis]
7 Wang B, Chen S, Li Y, Xuan J, Liu Y, Shi G. Targeted Therapy for Primary Sjögren's Syndrome: Where are We Now? BioDrugs 2021;35:593-610. [PMID: 34731460 DOI: 10.1007/s40259-021-00505-7] [Reference Citation Analysis]
8 Lin C, Chen H, Chang T, Hsu T, Hsu C, Su Y. Association of primary Sjögren’s syndrome with incident heart failure: a secondary analysis of health claims data in Taiwan. Therapeutic Advances in Chronic Disease 2022;13:204062232210780. [DOI: 10.1177/20406223221078083] [Reference Citation Analysis]
9 Eslambolchi A, Aghaghazvini L, Gholamrezanezhad A, Kavosi H, Radmard AR. Coronavirus disease 2019 (COVID-19) in patients with systemic autoimmune diseases or vasculitis: radiologic presentation. J Thromb Thrombolysis 2021;51:339-48. [PMID: 32981005 DOI: 10.1007/s11239-020-02289-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]